Telix Pharmaceuticals Ltd SEC filings TLPPF
Telix Pharmaceuticals Ltd has 109 filings in SEC EDGAR's recent list, going back to Jan 25, 2024. Its latest annual report, Form 20-F, was filed on Feb 20, 2026 for the period ended Dec 31, 2025. The most recent current report (Form 6-K) was filed on Oct 29, 2026. The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| UPLOAD | Letter from the SEC | Apr 23, 2026 | — |
| CORRESP | Letter to the SEC | Apr 17, 2026 | — |
| UPLOAD | Letter from the SEC | Apr 3, 2026 | — |
| SEC STAFF LETTER | Filing | Nov 21, 2024 | — |
| EFFECT | Filing | Nov 12, 2024 | — |
| SEC STAFF ACTION | Filing | Nov 12, 2024 | — |
| CERT | Filing | Nov 12, 2024 | — |
| CORRESP | Letter to the SEC | Nov 12, 2024 | — |
| 20FR12B/A | Filing | Oct 30, 2024 | — |
| SEC STAFF LETTER | Filing | Oct 28, 2024 | — |
| CORRESP | Letter to the SEC | Oct 17, 2024 | — |
| 20FR12B | Filing | Oct 17, 2024 | — |
| UPLOAD | Letter from the SEC | Oct 10, 2024 | — |
| DRS | Filing | Sep 13, 2024 | — |
| RW | Filing | Jun 14, 2024 | — |
| RW | Filing | Jun 14, 2024 | — |
| 8-A12B | Filing | Jun 10, 2024 | — |
| DRS/A | Filing | May 9, 2024 | — |
| DRS/A | Filing | Apr 15, 2024 | — |
| DRS/A | Filing | Mar 15, 2024 | — |
| DRS/A | Filing | Feb 2, 2024 | — |
| DRS | Filing | Jan 25, 2024 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TLX (Nasdaq), TLPPF (OTC)
- Fiscal year ends
- December 31
- Incorporated in
- Australia
- Headquarters
- North Melbourne, Australia
- SEC filer status
- Large accelerated filer
- SEC CIK
- 2007191
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.